SCHEMBL24677759

SCHEMBL24677759

COC(=O)c1ccccc1COc1ccc(OC)c(C=O)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.47
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HSP90AA1 P07900 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
LMNA P02545 2/20 0.42
HIF1A Q16665 1/20 0.41
HTT P42858 4/20 0.41
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25950573 0.91 ALDH1A1 (0.42) MRGPRX4ALDH1A1MAPTSMN1; SMN2HSP90AA1
SCHEMBL24677760 0.89 MRGPRX4 (0.46) MRGPRX4ALDH1A1MAPTSMN1; SMN2HSP90AA1
SCHEMBL30447357 0.89 MRGPRX4 (0.46) MRGPRX4ALDH1A1MAPTSMN1; SMN2HSP90AA1
SCHEMBL24677758 0.89 MRGPRX4 (0.46) MRGPRX4ALDH1A1MAPTSMN1; SMN2HSP90AA1
SCHEMBL24677801 0.89 HTT (0.50) MRGPRX4ALDH1A1MAPTSMN1; SMN2CYP2C9
SCHEMBL30558899 0.89 HTT (0.50) MRGPRX4ALDH1A1MAPTSMN1; SMN2CYP2C9
SCHEMBL25950565 0.79 LMNA (0.42) MRGPRX4ALDH1A1MAPTSMN1; SMN2HSP90AA1
SCHEMBL14691336 0.77 ALDH1A1 (0.50) ALDH1A1MAPTSMN1; SMN2HSP90AA1CYP1A2
SCHEMBL26507030 0.77 LMNA (0.39) ALDH1A1MAPTSMN1; SMN2CYP2C9LMNA
SCHEMBL29831705 0.77 MRGPRX4 (0.51) MRGPRX4ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4314004-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS Eli Lilly and Company (US) 2024-02-07 EP disclosed
CN-116888137-A Carboxy substituted glucocorticoid receptor agonists 伊莱利利公司 2023-10-13 CN disclosed
US-20230227493-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2023-07-20 US disclosed
US-20230227493-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2023-07-20 US disclosed
WO-2022204099-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2022-09-29 WO disclosed
US-20220306681-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227493-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, MC2R, NR3C2 MRGPRX4 28/4885ALDH1A1 2971/4885MAPT 4721/4885
US-20220306681-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, MC2R, NR3C2 MRGPRX4 28/4885ALDH1A1 2971/4885MAPT 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.